Synchrotron X-Ray Boost Delivered by Microbeam Radiation Therapy After Conventional X-Ray Therapy Fractionated in Time Improves F98 Glioma Control
- 20 February 2020
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 107 (2), 360-369
- https://doi.org/10.1016/j.ijrobp.2020.02.023
Abstract
No abstract availableFunding Information
- European Synchrotron Radiation Facility
- Institut National Du Cancer (PRTK17048, ANR-11-LABX-0063, ANR-11-IDEX-0007)
This publication has 26 references indexed in Scilit:
- Characterization of the 9L gliosarcoma implanted in the Fischer rat: an orthotopic model for a grade IV brain tumorTumor Biology, 2014
- Effects of pulsed, spatially fractionated, microscopic synchrotron X-ray beams on normal and tumoral brain tissueMutation research. Reviews in mutation research, 2010
- New technology enables high precision multislit collimators for microbeam radiation therapyReview of Scientific Instruments, 2009
- First trial of spatial and temporal fractionations of the delivered dose using synchrotron microbeam radiation therapyJournal of Synchrotron Radiation, 2009
- Rat brain tumor models in experimental neuro-oncology:The 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 GliomasJournal of Neuro-Oncology, 1998
- Microbeam radiation therapyMedical Physics, 1992
- Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomasRadiotherapy and Oncology, 1991
- Randomized Comparisons of Radiotherapy and Nitrosoureas for the Treatment of Malignant Glioma after SurgeryThe New England Journal of Medicine, 1980
- Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomasJournal of Neurosurgery, 1978
- Postoperative Irradiation of Glioblastomas: Results in a Randomized SeriesActa Radiologica: Oncology, Radiation, Physics, Biology, 1978